{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:17:55Z","timestamp":1792883875537,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"DOI":"10.1007\/s00726-024-03427-0","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T23:33:51Z","timestamp":1733268831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The application and prospects of antimicrobial peptides in antiviral therapy"],"prefix":"10.1007","volume":"56","author":[{"given":"Fei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"3427_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bcp.2016.09.018","volume":"133","author":"JM Ageitos","year":"2017","unstructured":"Ageitos JM, S\u00e1nchez-P\u00e9rez A, Calo-Mata P, Villa TG (2017) Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria. Biochem Pharmacol 133:117\u2013138. https:\/\/doi.org\/10.1016\/j.bcp.2016.09.018","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3427_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11274-024-03921-3","volume":"40","author":"S Alahyaribeik","year":"2024","unstructured":"Alahyaribeik S, Nazarpour M (2024) Peptide recovery from chicken feather keratin and their anti-biofilm properties against methicillin-resistant Staphylococcus aureus (MRSA). World J Microbiol Biotechnol 40(4):123. https:\/\/doi.org\/10.1007\/s11274-024-03921-3","journal-title":"World J Microbiol Biotechnol"},{"key":"3427_CR3","doi-asserted-by":"publisher","first-page":"880961","DOI":"10.3389\/fimmu.2022.880961","volume":"13","author":"KM Aloul","year":"2022","unstructured":"Aloul KM, Nielsen JE, Defensor EB, Lin JS, Fortkort JA, Shamloo M, Cirillo JD, Gombart AF, Barron AE (2022) Upregulating Human Cathelicidin Antimicrobial peptide LL-37 expression may prevent severe COVID-19 inflammatory responses and reduce microthrombosis. Front Immunol 13:880961. https:\/\/doi.org\/10.3389\/fimmu.2022.880961","journal-title":"Front Immunol"},{"issue":"1","key":"3427_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00018-021-04041-z","volume":"79","author":"AS Amiss","year":"2021","unstructured":"Amiss AS, von Pein JB, Webb JR, Condon ND, Harvey PJ, Phan MD, Schembri MA, Currie BJ, Sweet MJ, Craik DJ et al (2021) Modified horseshoe crab peptides target and kill bacteria inside host cells. Cell Mol Life Sci 79(1):38. https:\/\/doi.org\/10.1007\/s00018-021-04041-z","journal-title":"Cell Mol Life Sci"},{"key":"3427_CR5","doi-asserted-by":"publisher","first-page":"1359261","DOI":"10.3389\/fphar.2024.1359261","volume":"15","author":"C Appiah","year":"2024","unstructured":"Appiah C, Chen S, Pori AI, Retyunskiy V, Tzeng C, Zhao Y (2024) Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues. Front Pharmacol 15:1359261. https:\/\/doi.org\/10.3389\/fphar.2024.1359261","journal-title":"Front Pharmacol"},{"issue":"12","key":"3427_CR6","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.jiph.2023.09.006","volume":"16","author":"MV Arasu","year":"2023","unstructured":"Arasu MV, Al-Dhabi NA (2023) Antibacterial activity of peptides and bio-safety evaluation: in vitro and in vivo studies against bacterial and fungal pathogens. J Infect Public Health 16(12):2031\u20132037. https:\/\/doi.org\/10.1016\/j.jiph.2023.09.006","journal-title":"J Infect Public Health"},{"key":"3427_CR7","doi-asserted-by":"publisher","unstructured":"Bin Hafeez A, Jiang X, Bergen PJ, Zhu Y (2021) Antimicrobial peptides: An update on classifications and databases. Int J Mol Sci 22(21). https:\/\/doi.org\/10.3390\/ijms222111691","DOI":"10.3390\/ijms222111691"},{"key":"3427_CR8","doi-asserted-by":"publisher","first-page":"1328890","DOI":"10.3389\/fmicb.2023.1328890","volume":"14","author":"A Brakel","year":"2023","unstructured":"Brakel A, Grochow T, Fritsche S, Knappe D, Krizsan A, Fietz SA, Alber G, Hoffmann R, M\u00fcller U (2023) Evaluation of proline-rich antimicrobial peptides as potential lead structures for novel antimycotics against Cryptococcus neoformans. Front Microbiol 14:1328890. https:\/\/doi.org\/10.3389\/fmicb.2023.1328890","journal-title":"Front Microbiol"},{"key":"3427_CR9","doi-asserted-by":"publisher","first-page":"713960","DOI":"10.3389\/fimmu.2021.713960","volume":"12","author":"J Cai","year":"2021","unstructured":"Cai J, Cui X, Wang X, You L, Ji C, Cao Y (2021) A novel anti-infective peptide BCCY-1 with immunomodulatory activities. Front Immunol 12:713960. https:\/\/doi.org\/10.3389\/fimmu.2021.713960","journal-title":"Front Immunol"},{"issue":"2","key":"3427_CR10","doi-asserted-by":"publisher","first-page":"e0171567","DOI":"10.1371\/journal.pone.0171567","volume":"12","author":"P Cao","year":"2017","unstructured":"Cao P, Dou G, Cheng Y, Che J (2017) The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance. PLoS ONE 12(2):e0171567. https:\/\/doi.org\/10.1371\/journal.pone.0171567","journal-title":"PLoS ONE"},{"key":"3427_CR11","doi-asserted-by":"publisher","first-page":"121032","DOI":"10.1016\/j.carbpol.2023.121032","volume":"317","author":"T \u00c7elen","year":"2023","unstructured":"\u00c7elen T, Anumudu C, Miri T, Onyeaka H, Fernandez-Trillo P (2023) Nisin:Carboxymethylcellulose polyion complex (PIC) nanoparticles. Preparation and antimicrobial activity. Carbohydr Polym 317:121032. https:\/\/doi.org\/10.1016\/j.carbpol.2023.121032","journal-title":"Carbohydr Polym"},{"key":"3427_CR12","doi-asserted-by":"publisher","first-page":"114733","DOI":"10.1016\/j.addr.2023.114733","volume":"196","author":"A Cesaro","year":"2023","unstructured":"Cesaro A, Lin S, Pardi N, de la Fuente-Nunez C (2023) Advanced delivery systems for peptide antibiotics. Adv Drug Deliv Rev 196:114733. https:\/\/doi.org\/10.1016\/j.addr.2023.114733","journal-title":"Adv Drug Deliv Rev"},{"key":"3427_CR13","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.csbj.2022.05.002","volume":"20","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Chatterjee R, Chakravortty D (2022) Evolving and assembling to pierce through: evolutionary and structural aspects of antimicrobial peptides. Comput Struct Biotechnol J 20:2247\u20132258. https:\/\/doi.org\/10.1016\/j.csbj.2022.05.002","journal-title":"Comput Struct Biotechnol J"},{"key":"3427_CR14","doi-asserted-by":"publisher","unstructured":"Chianese A, Zannella C, Monti A, De Filippis A, Doti N, Franci G, Galdiero M (2022) The broad-spectrum antiviral potential of the Amphibian peptide AR-23. Int J Mol Sci 23(2). https:\/\/doi.org\/10.3390\/ijms23020883","DOI":"10.3390\/ijms23020883"},{"key":"3427_CR15","doi-asserted-by":"publisher","unstructured":"Chianese A, Zannella C, Monti A, Doti N, Sanna G, Manzin A, De Filippis A, Galdiero M (2023) Hylin-a1: a Pan-inhibitor against Emerging and re-emerging respiratory viruses. Int J Mol Sci 24(18). https:\/\/doi.org\/10.3390\/ijms241813888","DOI":"10.3390\/ijms241813888"},{"issue":"12","key":"3427_CR16","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1093\/jxb\/erab078","volume":"72","author":"MM Combest","year":"2021","unstructured":"Combest MM, Moroz N, Tanaka K, Rogan CJ, Anderson JC, Thura L, Rakotondrafara AM, Goyer A (2021) StPIP1, a PAMP-induced peptide in potato, elicits plant defenses and is associated with disease symptom severity in a compatible interaction with Potato virus Y. J Exp Bot 72(12):4472\u20134488. https:\/\/doi.org\/10.1093\/jxb\/erab078","journal-title":"J Exp Bot"},{"issue":"2","key":"3427_CR17","doi-asserted-by":"publisher","first-page":"e21358","DOI":"10.1096\/fj.202001885RR","volume":"35","author":"M De Angelis","year":"2021","unstructured":"De Angelis M, Casciaro B, Genovese A, Brancaccio D, Marcocci ME, Novellino E, Carotenuto A, Palamara AT, Mangoni ML, Nencioni L (2021) Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: insights into biological activity and mechanism of action. Faseb j 35(2):e21358. https:\/\/doi.org\/10.1096\/fj.202001885RR","journal-title":"Faseb j"},{"issue":"6","key":"3427_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bcp.2012.12.011","volume":"85","author":"E De Clercq","year":"2013","unstructured":"De Clercq E (2013) Antivirals: past, present and future. Biochem Pharmacol 85(6):727\u2013744. https:\/\/doi.org\/10.1016\/j.bcp.2012.12.011","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"3427_CR19","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.peptides.2010.07.028","volume":"31","author":"RE Dean","year":"2010","unstructured":"Dean RE, O\u2019Brien LM, Thwaite JE, Fox MA, Atkins H, Ulaeto DO (2010) A carpet-based mechanism for direct antimicrobial peptide activity against Vaccinia virus membranes. Peptides 31(11):1966\u20131972. https:\/\/doi.org\/10.1016\/j.peptides.2010.07.028","journal-title":"Peptides"},{"key":"3427_CR20","doi-asserted-by":"publisher","unstructured":"Diamond G, Molchanova N, Herlan C, Fortkort JA, Lin JS, Figgins E, Bopp N, Ryan LK, Chung D, Adcock RS et al (2021) Potent antiviral activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids. Pharmaceuticals (Basel) 14(4). https:\/\/doi.org\/10.3390\/ph14040304","DOI":"10.3390\/ph14040304"},{"key":"3427_CR21","doi-asserted-by":"publisher","first-page":"113189","DOI":"10.1016\/j.biopha.2022.113189","volume":"151","author":"PN Dlozi","year":"2022","unstructured":"Dlozi PN, Gladchuk A, Crutchley RD, Keuler N, Coetzee R, Dube A (2022) Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes. Biomed Pharmacother 151:113189. https:\/\/doi.org\/10.1016\/j.biopha.2022.113189","journal-title":"Biomed Pharmacother"},{"key":"3427_CR22","doi-asserted-by":"publisher","first-page":"1119574","DOI":"10.3389\/fimmu.2023.1119574","volume":"14","author":"DI Duarte-Mata","year":"2023","unstructured":"Duarte-Mata DI, Salinas-Carmona MC (2023) Antimicrobial peptides\u00b4 immune modulation role in intracellular bacterial infection. Front Immunol 14:1119574. https:\/\/doi.org\/10.3389\/fimmu.2023.1119574","journal-title":"Front Immunol"},{"issue":"10","key":"3427_CR23","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00726-020-02903-7","volume":"52","author":"M Faya","year":"2020","unstructured":"Faya M, Hazzah HA, Omolo CA, Agrawal N, Maji R, Walvekar P, Mocktar C, Nkambule B, Rambharose S, Albericio F et al (2020) Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). Amino Acids 52(10):1439\u20131457. https:\/\/doi.org\/10.1007\/s00726-020-02903-7","journal-title":"Amino Acids"},{"key":"3427_CR24","doi-asserted-by":"publisher","unstructured":"Feng M, Fei S, Xia J, Labropoulou V, Swevers L, Sun J (2020) Antimicrobial Peptides as Potential Antiviral Factors in Insect Antiviral Immune Response. Front Immunol 11: 2030. https:\/\/doi.org\/10.3389\/fimmu.2020.02030","DOI":"10.3389\/fimmu.2020.02030"},{"key":"3427_CR25","doi-asserted-by":"publisher","first-page":"112693","DOI":"10.1016\/j.colsurfb.2022.112693","volume":"217","author":"ED Freitas","year":"2022","unstructured":"Freitas ED, Bataglioli RA, Oshodi J, Beppu MM (2022) Antimicrobial peptides and their potential application in antiviral coating agents. Colloids Surf B Biointerfaces 217:112693. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112693","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"3427_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2174\/1568026616666160713143331","volume":"17","author":"KE Greber","year":"2017","unstructured":"Greber KE, Dawgul M (2017) Antimicrobial peptides under clinical trials. Curr Top Med Chem 17(5):620\u2013628. https:\/\/doi.org\/10.2174\/1568026616666160713143331","journal-title":"Curr Top Med Chem"},{"key":"3427_CR27","doi-asserted-by":"publisher","unstructured":"Gudima G, Kofiadi I, Shilovskiy I, Kudlay D, Khaitov M (2023) Antiviral therapy of COVID-19. Int J Mol Sci 24(10). https:\/\/doi.org\/10.3390\/ijms24108867","DOI":"10.3390\/ijms24108867"},{"key":"3427_CR28","doi-asserted-by":"publisher","first-page":"1405760","DOI":"10.3389\/fmicb.2024.1405760","volume":"15","author":"MES Guerra","year":"2024","unstructured":"Guerra MES, Vieira B, Calazans A, Destro GV, Melo K, Rodrigues E, Waz NT, Girardello R, Darrieux M, Converso TR (2024) Recent advances in the therapeutic potential of cathelicidins. Front Microbiol 15:1405760. https:\/\/doi.org\/10.3389\/fmicb.2024.1405760","journal-title":"Front Microbiol"},{"issue":"7","key":"3427_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Peacock SJ et al (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 19(7):409\u2013424. https:\/\/doi.org\/10.1038\/s41579-021-00573-0","journal-title":"Nat Rev Microbiol"},{"key":"3427_CR30","doi-asserted-by":"publisher","first-page":"170526","DOI":"10.1016\/j.peptides.2021.170526","volume":"139","author":"H Heydari","year":"2021","unstructured":"Heydari H, Golmohammadi R, Mirnejad R, Tebyanian H, Fasihi-Ramandi M, Moosazadeh Moghaddam M (2021) Antiviral peptides against Coronaviridae family: a review. Peptides 139:170526. https:\/\/doi.org\/10.1016\/j.peptides.2021.170526","journal-title":"Peptides"},{"key":"3427_CR31","doi-asserted-by":"publisher","unstructured":"Hsieh IN, Hartshorn KL (2016) The role of antimicrobial peptides in Influenza Virus infection and their potential as antiviral and immunomodulatory therapy. Pharmaceuticals (Basel) 9(3). https:\/\/doi.org\/10.3390\/ph9030053","DOI":"10.3390\/ph9030053"},{"key":"3427_CR32","doi-asserted-by":"publisher","first-page":"105146","DOI":"10.1016\/j.dci.2024.105146","volume":"154","author":"J Hu","year":"2024","unstructured":"Hu J, Li S, Miao M, Li F (2024) Characterization of the antibacterial and opsonic functions of the antimicrobial peptide LvCrustinVI from Litopenaeus vannamei. Dev Comp Immunol 154:105146. https:\/\/doi.org\/10.1016\/j.dci.2024.105146","journal-title":"Dev Comp Immunol"},{"key":"3427_CR33","doi-asserted-by":"publisher","first-page":"582779","DOI":"10.3389\/fmicb.2020.582779","volume":"11","author":"Y Huan","year":"2020","unstructured":"Huan Y, Kong Q, Mou H, Yi H (2020) Antimicrobial peptides: classification, design, application and research progress in multiple fields. Front Microbiol 11:582779. https:\/\/doi.org\/10.3389\/fmicb.2020.582779","journal-title":"Front Microbiol"},{"key":"3427_CR34","doi-asserted-by":"publisher","unstructured":"Huang Y, Zhang P, Han S, He H (2023) Lactoferrin alleviates inflammation and regulates gut microbiota composition in H5N1-Infected mice. Nutrients 15(15). https:\/\/doi.org\/10.3390\/nu15153362","DOI":"10.3390\/nu15153362"},{"issue":"9","key":"3427_CR35","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.tim.2018.05.013","volume":"26","author":"EC Hutchinson","year":"2018","unstructured":"Hutchinson EC (2018) Influenza virus. Trends Microbiol 26(9):809\u2013810. https:\/\/doi.org\/10.1016\/j.tim.2018.05.013","journal-title":"Trends Microbiol"},{"key":"3427_CR36","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3389\/fimmu.2020.01221","volume":"11","author":"DB Kell","year":"2020","unstructured":"Kell DB, Heyden EL, Pretorius E (2020) The Biology of Lactoferrin, an Iron-binding protein that can help defend against viruses and Bacteria. Front Immunol 11:1221. https:\/\/doi.org\/10.3389\/fimmu.2020.01221","journal-title":"Front Immunol"},{"key":"3427_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.antiviral.2013.11.004","volume":"101","author":"A Kilianski","year":"2014","unstructured":"Kilianski A, Baker SC (2014) Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors. Antiviral Res 101:105\u2013112. https:\/\/doi.org\/10.1016\/j.antiviral.2013.11.004","journal-title":"Antiviral Res"},{"key":"3427_CR38","doi-asserted-by":"publisher","unstructured":"Koksharova O, Safronova N, Dunina-Barkovskaya A (2022) New Antimicrobial peptide with two CRAC motifs: activity against Escherichia coli and Bacillus subtilis. Microorganisms 10(8). https:\/\/doi.org\/10.3390\/microorganisms10081538","DOI":"10.3390\/microorganisms10081538"},{"issue":"5","key":"3427_CR39","doi-asserted-by":"publisher","first-page":"e1823","DOI":"10.1002\/wnan.1823","volume":"14","author":"E Kolanthai","year":"2022","unstructured":"Kolanthai E, Neal CJ, Kumar U, Fu Y, Seal S (2022) Antiviral nanopharmaceuticals: Engineered surface interactions and virus-selective activity. Wiley Interdiscip Rev Nanomed Nanobiotechnol 14(5):e1823. https:\/\/doi.org\/10.1002\/wnan.1823","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"3","key":"3427_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1021\/acsinfecdis.8b00319","volume":"5","author":"P Kumar","year":"2019","unstructured":"Kumar P, Pletzer D, Haney EF, Rahanjam N, Cheng JTJ, Yue M, Aljehani W, Hancock REW, Kizhakkedathu JN, Straus SK (2019) Aurein-derived antimicrobial peptides formulated with Pegylated Phospholipid micelles to target Methicillin-resistant Staphylococcus aureus skin infections. ACS Infect Dis 5(3):443\u2013453. https:\/\/doi.org\/10.1021\/acsinfecdis.8b00319","journal-title":"ACS Infect Dis"},{"key":"3427_CR41","doi-asserted-by":"publisher","unstructured":"Lee C (2019) Griffithsin, a highly potent broad-spectrum antiviral lectin from Red Algae: from Discovery to Clinical Application. Mar Drugs 17(10). https:\/\/doi.org\/10.3390\/md17100567","DOI":"10.3390\/md17100567"},{"key":"3427_CR42","doi-asserted-by":"publisher","unstructured":"Lee YJ, Shirkey JD, Park J, Bisht K, Cowan AJ (2022) An overview of antiviral peptides and rational Biodesign considerations. Biodes Res 2022(9898241). https:\/\/doi.org\/10.34133\/2022\/9898241","DOI":"10.34133\/2022\/9898241"},{"issue":"7","key":"3427_CR43","first-page":"3919","volume":"11","author":"J Lei","year":"2019","unstructured":"Lei J, Sun L, Huang S, Zhu C, Li P, He J, Mackey V, Coy DH, He Q (2019) The antimicrobial peptides and their potential clinical applications. Am J Transl Res 11(7):3919\u20133931","journal-title":"Am J Transl Res"},{"key":"3427_CR44","doi-asserted-by":"publisher","unstructured":"Li X, Zuo S, Wang B, Zhang K, Wang Y (2022) Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides. Molecules 27(9). https:\/\/doi.org\/10.3390\/molecules27092675","DOI":"10.3390\/molecules27092675"},{"key":"3427_CR45","doi-asserted-by":"publisher","first-page":"174612","DOI":"10.1016\/j.scitotenv.2024.174612","volume":"947","author":"Z Li","year":"2024","unstructured":"Li Z, Ouyang L, Lu Y, Peng Q, Qiao X, Wu Q, Zhang B, Liu B, Wan F, Qian W (2024) Antibiotics suppress the expression of antimicrobial peptides and increase sensitivity of Cydia pomonella to granulosis virus. Sci Total Environ 947:174612. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.174612","journal-title":"Sci Total Environ"},{"issue":"24","key":"3427_CR47","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1007\/s00253-020-10993-2","volume":"104","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ma A, Han P, Chen Z, Jia Y (2020) Antibacterial mechanism of brevilaterin B: an amphiphilic lipopeptide targeting the membrane of Listeria monocytogenes. Appl Microbiol Biotechnol 104(24):10531\u201310539. https:\/\/doi.org\/10.1007\/s00253-020-10993-2","journal-title":"Appl Microbiol Biotechnol"},{"key":"3427_CR46","doi-asserted-by":"publisher","unstructured":"Liu Q, Wang L, He D, Wu Y, Liu X, Yang Y, Chen Z, Dong Z, Luo Y, Song Y (2023) Application value of antimicrobial peptides in gastrointestinal tumors. Int J Mol Sci 24(23). https:\/\/doi.org\/10.3390\/ijms242316718","DOI":"10.3390\/ijms242316718"},{"issue":"1","key":"3427_CR48","doi-asserted-by":"publisher","first-page":"e3534","DOI":"10.1002\/psc.3534","volume":"30","author":"MR Loffredo","year":"2024","unstructured":"Loffredo MR, Nencioni L, Mangoni ML, Casciaro B (2024) Antimicrobial peptides for novel antiviral strategies in the current post-COVID-19 pandemic. J Pept Sci 30(1):e3534. https:\/\/doi.org\/10.1002\/psc.3534","journal-title":"J Pept Sci"},{"key":"3427_CR50","doi-asserted-by":"publisher","unstructured":"Luo Y, Song Y (2021) Mechanism of antimicrobial peptides: Antimicrobial, anti-inflammatory and Antibiofilm activities. Int J Mol Sci 22(21). https:\/\/doi.org\/10.3390\/ijms222111401","DOI":"10.3390\/ijms222111401"},{"key":"3427_CR49","doi-asserted-by":"publisher","unstructured":"Luo X, Wu W, Feng L, Treves H, Ren M (2021) Short peptides make a big difference: the role of Botany-Derived AMPs in Disease Control and Protection of Human Health. Int J Mol Sci 22(21). https:\/\/doi.org\/10.3390\/ijms222111363","DOI":"10.3390\/ijms222111363"},{"key":"3427_CR51","doi-asserted-by":"publisher","first-page":"100627","DOI":"10.1016\/j.nmni.2019.100627","volume":"34","author":"H Madanchi","year":"2020","unstructured":"Madanchi H, Shoushtari M, Kashani HH, Sardari S (2020) Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases. New Microbes New Infect 34:100627. https:\/\/doi.org\/10.1016\/j.nmni.2019.100627","journal-title":"New Microbes New Infect"},{"issue":"1","key":"3427_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10096-019-03674-0","volume":"39","author":"H Memariani","year":"2020","unstructured":"Memariani H, Memariani M, Moravvej H, Shahidi-Dadras M (2020) Melittin: a venom-derived peptide with promising anti-viral properties. Eur J Clin Microbiol Infect Dis 39(1):5\u201317. https:\/\/doi.org\/10.1007\/s10096-019-03674-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3427_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2016.07.011","volume":"133","author":"JK Millet","year":"2016","unstructured":"Millet JK, S\u00e9ron K, Labitt RN, Danneels A, Palmer KE, Whittaker GR, Dubuisson J, Belouzard S (2016) Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin. Antiviral Res 133:1\u20138. https:\/\/doi.org\/10.1016\/j.antiviral.2016.07.011","journal-title":"Antiviral Res"},{"issue":"10","key":"3427_CR54","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/14787210.2021.1912593","volume":"19","author":"MS Mousavi Maleki","year":"2021","unstructured":"Mousavi Maleki MS, Rostamian M, Madanchi H (2021) Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2. Expert Rev Anti Infect Ther 19(10):1205\u20131217. https:\/\/doi.org\/10.1080\/14787210.2021.1912593","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"3427_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10989-022-10477-z","volume":"29","author":"MS Mousavi Maleki","year":"2023","unstructured":"Mousavi Maleki MS, Sardari S, Ghandehari Alavijeh A, Madanchi H (2023) Recent patents and FDA-Approved drugs based on antiviral peptides and other peptide-related antivirals. Int J Pept Res Ther 29(1):5. https:\/\/doi.org\/10.1007\/s10989-022-10477-z","journal-title":"Int J Pept Res Ther"},{"key":"3427_CR56","doi-asserted-by":"publisher","unstructured":"Nastri BM, Chianese A, Giugliano R, Di Clemente L, Capasso C, Monti A, Doti N, Iovane V, Montagnaro S, Pagnini U et al (2024) Oreoch-1: a broad-spectrum virus and host-targeting peptide against animal infections. J Pept Sci e3593. https:\/\/doi.org\/10.1002\/psc.3593","DOI":"10.1002\/psc.3593"},{"issue":"1","key":"3427_CR57","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1038\/s41598-017-03745-2","volume":"7","author":"W Nawae","year":"2017","unstructured":"Nawae W, Hannongbua S, Ruengjitchatchawalya M (2017) Molecular dynamics exploration of poration and leaking caused by Kalata B1 in HIV-infected cell membrane compared to host and HIV membranes. Sci Rep 7(1):3638. https:\/\/doi.org\/10.1038\/s41598-017-03745-2","journal-title":"Sci Rep"},{"issue":"3","key":"3427_CR58","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/s2352-3018(19)30407-2","volume":"7","author":"JT Okano","year":"2020","unstructured":"Okano JT, Sharp K, Valdano E, Palk L, Blower S (2020) HIV transmission and source-sink dynamics in sub-saharan Africa. Lancet HIV 7(3):e209\u2013e214. https:\/\/doi.org\/10.1016\/s2352-3018(19)30407-2","journal-title":"Lancet HIV"},{"issue":"11","key":"3427_CR59","doi-asserted-by":"publisher","first-page":"e0278419","DOI":"10.1371\/journal.pone.0278419","volume":"17","author":"AAM Omer","year":"2022","unstructured":"Omer AAM, Hinkula J, Tran PT, Melik W, Zattarin E, Aili D, Seleg\u00e5rd R, Bengtsson T, Khalaf H (2022) Plantaricin NC8 \u03b1\u03b2 rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes. PLoS ONE 17(11):e0278419. https:\/\/doi.org\/10.1371\/journal.pone.0278419","journal-title":"PLoS ONE"},{"issue":"2","key":"3427_CR60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/coh.0000000000000344","volume":"12","author":"UM Parikh","year":"2017","unstructured":"Parikh UM, McCormick K, van Zyl G, Mellors JW (2017) Future technologies for monitoring HIV drug resistance and cure. Curr Opin HIV AIDS 12(2):182\u2013189. https:\/\/doi.org\/10.1097\/coh.0000000000000344","journal-title":"Curr Opin HIV AIDS"},{"key":"3427_CR61","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.biopha.2017.09.042","volume":"95","author":"S Patel","year":"2017","unstructured":"Patel S, Akhtar N (2017) Antimicrobial peptides (AMPs): the quintessential \u2018offense and defense\u2019 molecules are more than antimicrobials. Biomed Pharmacother 95:1276\u20131283. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.042","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3427_CR62","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.psj.2023.102695","volume":"102","author":"T Pimchan","year":"2023","unstructured":"Pimchan T, Tian F, Thumanu K, Rodtong S, Yongsawatdigul J (2023) Isolation, identification, and mode of action of antibacterial peptides derived from egg yolk hydrolysate. Poult Sci 102(7):102695. https:\/\/doi.org\/10.1016\/j.psj.2023.102695","journal-title":"Poult Sci"},{"issue":"6","key":"3427_CR63","doi-asserted-by":"publisher","first-page":"e0156929","DOI":"10.1371\/journal.pone.0156929","volume":"11","author":"O Pinkenburg","year":"2016","unstructured":"Pinkenburg O, Meyer T, Bannert N, Norley S, Bolte K, Czudai-Matwich V, Herold S, Gessner A, Schnare M (2016) The human antimicrobial protein Bactericidal\/Permeability-Increasing protein (BPI) inhibits the infectivity of Influenza A Virus. PLoS ONE 11(6):e0156929. https:\/\/doi.org\/10.1371\/journal.pone.0156929","journal-title":"PLoS ONE"},{"issue":"5","key":"3427_CR64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/17460441.2022.2050693","volume":"17","author":"P Rani","year":"2022","unstructured":"Rani P, Kapoor B, Gulati M, Atanasov AG, Alzahrani Q, Gupta R (2022) Antimicrobial peptides: a plausible approach for COVID-19 treatment. Expert Opin Drug Discov 17(5):473\u2013487. https:\/\/doi.org\/10.1080\/17460441.2022.2050693","journal-title":"Expert Opin Drug Discov"},{"key":"3427_CR65","doi-asserted-by":"publisher","unstructured":"Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK (2020) Caerin 1 antimicrobial peptides that inhibit HIV and Neisseria May spare protective lactobacilli. Antibiot (Basel) 9(10). https:\/\/doi.org\/10.3390\/antibiotics9100661","DOI":"10.3390\/antibiotics9100661"},{"key":"3427_CR66","doi-asserted-by":"publisher","first-page":"127206","DOI":"10.1016\/j.micres.2022.127206","volume":"265","author":"J Saini","year":"2022","unstructured":"Saini J, Kaur P, Malik N, Lakhawat SS, Sharma PK (2022) Antimicrobial peptides: a promising tool to combat multidrug resistance in SARS CoV2 era. Microbiol Res 265:127206. https:\/\/doi.org\/10.1016\/j.micres.2022.127206","journal-title":"Microbiol Res"},{"key":"3427_CR67","doi-asserted-by":"publisher","unstructured":"Samuels S, Alwan Z, Egnin M, Jaynes J, Connell TD, Bernard GC, Nashar T (2017) Novel Therapeutic Approach for Inhibition of HIV-1 using cell-penetrating peptide and bacterial toxins. J AIDS Clin Res 8(10). https:\/\/doi.org\/10.4172\/2155-6113.1000737","DOI":"10.4172\/2155-6113.1000737"},{"key":"3427_CR68","doi-asserted-by":"publisher","first-page":"1271757","DOI":"10.3389\/fpls.2023.1271757","volume":"14","author":"N Shcherbak","year":"2023","unstructured":"Shcherbak N, Prochaska H, Lystvan K, Prokhorova Y, Giritch A, Kuchuk M (2023) Accumulation of colicin M protein and its biological activity in transgenic lettuce and mizuna plants. Front Plant Sci 14:1271757. https:\/\/doi.org\/10.3389\/fpls.2023.1271757","journal-title":"Front Plant Sci"},{"issue":"10","key":"3427_CR69","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.3390\/v7102883","volume":"7","author":"S Skalickova","year":"2015","unstructured":"Skalickova S, Heger Z, Krejcova L, Pekarik V, Bastl K, Janda J, Kostolansky F, Vareckova E, Zitka O, Adam V et al (2015) Perspective of Use of antiviral peptides against Influenza Virus. Viruses 7(10):5428\u20135442. https:\/\/doi.org\/10.3390\/v7102883","journal-title":"Viruses"},{"key":"3427_CR70","doi-asserted-by":"publisher","first-page":"104930","DOI":"10.1016\/j.micpath.2021.104930","volume":"155","author":"SS Solanki","year":"2021","unstructured":"Solanki SS, Singh P, Kashyap P, Sansi MS, Ali SA (2021) Promising role of defensins peptides as therapeutics to combat against viral infection. Microb Pathog 155:104930. https:\/\/doi.org\/10.1016\/j.micpath.2021.104930","journal-title":"Microb Pathog"},{"key":"3427_CR71","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijbiomac.2020.07.174","volume":"164","author":"PFN Souza","year":"2020","unstructured":"Souza PFN, Lopes FES, Amaral JL, Freitas CDT, Oliveira JTA (2020) A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor. Int J Biol Macromol 164:66\u201376. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.174","journal-title":"Int J Biol Macromol"},{"key":"3427_CR72","doi-asserted-by":"publisher","unstructured":"Sukmarini L (2022) Antiviral peptides (AVPs) of Marine Origin as propitious therapeutic drug candidates for the treatment of human viruses. Molecules 27(9). https:\/\/doi.org\/10.3390\/molecules27092619","DOI":"10.3390\/molecules27092619"},{"key":"3427_CR73","doi-asserted-by":"publisher","unstructured":"Sultana A, Luo H, Ramakrishna S (2021) Antimicrobial peptides and their applications in Biomedical Sector. Antibiot (Basel) 10(9). https:\/\/doi.org\/10.3390\/antibiotics10091094","DOI":"10.3390\/antibiotics10091094"},{"key":"3427_CR74","doi-asserted-by":"publisher","unstructured":"Talapko J, Me\u0161trovi\u0107 T, Juzba\u0161i\u0107 M, Tomas M, Eri\u0107 S, Horvat Aleksijevi\u0107 L, Beki\u0107 S, Schwarz D, Mati\u0107 S, Neuberg M et al (2022) Antimicrobial peptides-mechanisms of Action, Antimicrobial effects and clinical applications. Antibiot (Basel) 11(10). https:\/\/doi.org\/10.3390\/antibiotics11101417","DOI":"10.3390\/antibiotics11101417"},{"key":"3427_CR75","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.idm.2020.02.001","volume":"5","author":"B Tang","year":"2020","unstructured":"Tang B, Bragazzi NL, Li Q, Tang S, Xiao Y, Wu J (2020) An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model 5:248\u2013255. https:\/\/doi.org\/10.1016\/j.idm.2020.02.001","journal-title":"Infect Dis Model"},{"key":"3427_CR76","doi-asserted-by":"publisher","unstructured":"Tang Z, Ma Q, Chen X, Chen T, Ying Y, Xi X, Wang L, Ma C, Shaw C, Zhou M (2021) Recent advances and challenges in Nanodelivery Systems for antimicrobial peptides (AMPs). Antibiot (Basel) 10(8). https:\/\/doi.org\/10.3390\/antibiotics10080990","DOI":"10.3390\/antibiotics10080990"},{"key":"3427_CR77","doi-asserted-by":"publisher","unstructured":"Urmi UL, Vijay AK, Willcox MDP, Attard S, Enninful G, Kumar N, Islam S, Kuppusamy R (2024) Exploring the efficacy of peptides and mimics against Influenza A Virus, Adenovirus, and murine norovirus. Int J Mol Sci 25(13). https:\/\/doi.org\/10.3390\/ijms25137030","DOI":"10.3390\/ijms25137030"},{"issue":"2","key":"3427_CR78","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/cbdd.12937","volume":"92","author":"T Vineeth Kumar","year":"2018","unstructured":"Vineeth Kumar T, Asha R, Shyla G, George S (2018) Identification and characterization of novel host defense peptides from the skin secretion of the fungoid frog, Hydrophylax bahuvistara (Anura: Ranidae). Chem Biol Drug Des 92(2):1409\u20131418. https:\/\/doi.org\/10.1111\/cbdd.12937","journal-title":"Chem Biol Drug Des"},{"issue":"2","key":"3427_CR79","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00726-021-03098-1","volume":"54","author":"VK Vishvakarma","year":"2022","unstructured":"Vishvakarma VK, Singh MB, Jain P, Kumari K, Singh P (2022) Hunting the main protease of SARS-CoV-2 by plitidepsin: molecular docking and temperature-dependent molecular dynamics simulations. Amino Acids 54(2):205\u2013213. https:\/\/doi.org\/10.1007\/s00726-021-03098-1","journal-title":"Amino Acids"},{"key":"3427_CR80","doi-asserted-by":"publisher","unstructured":"Wan X, Wang W, Zhu J, Xiao Y (2024) Antibacterial peptide Reg4 ameliorates Pseudomonas aeruginosa-induced pulmonary inflammation and fibrosis. Microbiol Spectr e0390523. https:\/\/doi.org\/10.1128\/spectrum.03905-23","DOI":"10.1128\/spectrum.03905-23"},{"key":"3427_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-0900-2_1","volume":"2203","author":"Y Wang","year":"2020","unstructured":"Wang Y, Grunewald M, Perlman S (2020) Coronaviruses: an updated overview of their replication and Pathogenesis. Methods Mol Biol 2203:1\u201329. https:\/\/doi.org\/10.1007\/978-1-0716-0900-2_1","journal-title":"Methods Mol Biol"},{"key":"3427_CR82","doi-asserted-by":"publisher","first-page":"928050","DOI":"10.3389\/fcimb.2022.928050","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Moon A, Huang J, Sun Y, Qiu HJ (2022) Antiviral effects and underlying mechanisms of Probiotics as Promising antivirals. Front Cell Infect Microbiol 12:928050. https:\/\/doi.org\/10.3389\/fcimb.2022.928050","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"3427_CR83","doi-asserted-by":"publisher","first-page":"110880","DOI":"10.1016\/j.celrep.2022.110880","volume":"39","author":"X Wei","year":"2022","unstructured":"Wei X, Zhang L, Yang Y, Hou Y, Xu Y, Wang Z, Su H, Han F, Han J, Liu P et al (2022) LL-37 transports immunoreactive cGAMP to activate STING signaling and enhance interferon-mediated host antiviral immunity. Cell Rep 39(9):110880. https:\/\/doi.org\/10.1016\/j.celrep.2022.110880","journal-title":"Cell Rep"},{"issue":"6532","key":"3427_CR84","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.abf4058","volume":"371","author":"KM White","year":"2021","unstructured":"White KM, Rosales R, Yildiz S, Kehrer T, Miorin L, Moreno E, Jangra S, Uccellini MB, Rathnasinghe R, Coughlan L et al (2021) Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science 371(6532):926\u2013931. https:\/\/doi.org\/10.1126\/science.abf4058","journal-title":"Science"},{"key":"3427_CR85","doi-asserted-by":"publisher","unstructured":"Wu Q, Pato\u010dka J, Ku\u010da K (2018) Insect antimicrobial peptides, a Mini Review. Toxins (Basel) 10(11). https:\/\/doi.org\/10.3390\/toxins10110461","DOI":"10.3390\/toxins10110461"},{"issue":"11","key":"3427_CR86","doi-asserted-by":"publisher","first-page":"e0187565","DOI":"10.1371\/journal.pone.0187565","volume":"12","author":"KC Wuerth","year":"2017","unstructured":"Wuerth KC, Falsafi R, Hancock REW (2017) Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection. PLoS ONE 12(11):e0187565. https:\/\/doi.org\/10.1371\/journal.pone.0187565","journal-title":"PLoS ONE"},{"issue":"4","key":"3427_CR87","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","volume":"30","author":"S Xia","year":"2020","unstructured":"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S et al (2020) Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res 30(4):343\u2013355. https:\/\/doi.org\/10.1038\/s41422-020-0305-x","journal-title":"Cell Res"},{"key":"3427_CR88","doi-asserted-by":"publisher","unstructured":"Xie F, Zan Y, Zhang X, Zhang H, Jin M, Zhang W, Zhang Y, Liu S (2020) Differential abilities of mammalian cathelicidins to inhibit bacterial biofilm formation and promote multifaceted Immune functions of neutrophils. Int J Mol Sci 21(5). https:\/\/doi.org\/10.3390\/ijms21051871","DOI":"10.3390\/ijms21051871"},{"key":"3427_CR89","doi-asserted-by":"publisher","unstructured":"Xiong W, Li J, Feng Y, Chai J, Wu J, Hu Y, Tian M, Lu W, Xu X, Zou M (2021) Brevinin-2GHk, a peptide derived from the skin of Fejervarya limnocharis, inhibits Zika Virus infection by disrupting viral Integrity. Viruses 13(12). https:\/\/doi.org\/10.3390\/v13122382","DOI":"10.3390\/v13122382"},{"key":"3427_CR90","doi-asserted-by":"publisher","unstructured":"Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W et al (2021) Human defensins inhibit SARS-CoV-2 infection by blocking viral entry. Viruses 13(7). https:\/\/doi.org\/10.3390\/v13071246","DOI":"10.3390\/v13071246"},{"issue":"6","key":"3427_CR91","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/jb\/mvab019","volume":"169","author":"J Yang","year":"2021","unstructured":"Yang J, Zhang B, Huang Y, Liu T, Zeng B, Chai J, Wu J, Xu X (2021) Antiviral activity and mechanism of ESC-1GN from skin secretion of Hylarana guentheri against influenza a virus. J Biochem 169(6):757\u2013765. https:\/\/doi.org\/10.1093\/jb\/mvab019","journal-title":"J Biochem"},{"key":"3427_CR92","doi-asserted-by":"publisher","unstructured":"Ye M, Liao Y, Wu L, Qi W, Choudhry N, Liu Y, Chen W, Song G, Chen J (2020) An oleanolic acid derivative inhibits hemagglutinin-mediated entry of Influenza A Virus. Viruses 12(2). https:\/\/doi.org\/10.3390\/v12020225","DOI":"10.3390\/v12020225"},{"issue":"4","key":"3427_CR93","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00726-023-03245-w","volume":"55","author":"Y You","year":"2023","unstructured":"You Y, Liu H, Zhu Y, Zheng H (2023) Rational design of stapled antimicrobial peptides. Amino Acids 55(4):421\u2013442. https:\/\/doi.org\/10.1007\/s00726-023-03245-w","journal-title":"Amino Acids"},{"key":"3427_CR94","doi-asserted-by":"publisher","unstructured":"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M et al (2022) Broad-spectrum antiviral activity of the Amphibian Antimicrobial peptide temporin L and its analogs. Int J Mol Sci 23(4). https:\/\/doi.org\/10.3390\/ijms23042060","DOI":"10.3390\/ijms23042060"},{"issue":"23","key":"3427_CR95","doi-asserted-by":"publisher","first-page":"10709","DOI":"10.1021\/acs.jmedchem.8b01358","volume":"61","author":"B Zeng","year":"2018","unstructured":"Zeng B, Chai J, Deng Z, Ye T, Chen W, Li D, Chen X, Chen M, Xu X (2018) Functional characterization of a Novel lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide in Vitro and in vivo. J Med Chem 61(23):10709\u201310723. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01358","journal-title":"J Med Chem"},{"issue":"21","key":"3427_CR96","doi-asserted-by":"publisher","first-page":"14701","DOI":"10.1021\/acs.jmedchem.2c01238","volume":"65","author":"M Zhang","year":"2022","unstructured":"Zhang M, Ouyang J, Fu L, Xu C, Ge Y, Sun S, Li X, Lai S, Ke H, Yuan B et al (2022) Hydrophobicity determines the bacterial killing rate of \u03b1-Helical antimicrobial peptides and influences the bacterial Resistance Development. J Med Chem 65(21):14701\u201314720. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01238","journal-title":"J Med Chem"},{"issue":"1","key":"3427_CR97","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00253-024-13101-w","volume":"108","author":"X Zheng","year":"2024","unstructured":"Zheng X, Yang N, Mao R, Hao Y, Teng D, Wang J (2024) Pharmacokinetics and pharmacodynamics of antibacterial peptide NZX in Staphylococcus aureus mastitis mouse model. Appl Microbiol Biotechnol 108(1):260. https:\/\/doi.org\/10.1007\/s00253-024-13101-w","journal-title":"Appl Microbiol Biotechnol"},{"key":"3427_CR98","doi-asserted-by":"publisher","first-page":"171177","DOI":"10.1016\/j.peptides.2024.171177","volume":"175","author":"K Zou","year":"2024","unstructured":"Zou K, Zhang S, Yin K, Ren S, Zhang M, Li X, Fan L, Zhang R, Li R (2024) Studies on the in vitro mechanism and in vivo therapeutic effect of the antimicrobial peptide ACP5 against Trichophyton mentagrophytes. Peptides 175:171177. https:\/\/doi.org\/10.1016\/j.peptides.2024.171177","journal-title":"Peptides"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-024-03427-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-024-03427-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-024-03427-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T14:03:20Z","timestamp":1734444200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-024-03427-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3427"],"URL":"https:\/\/doi.org\/10.1007\/s00726-024-03427-0","relation":{},"ISSN":["1438-2199"],"issn-type":[{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}